Regains Compliance With Nasdaq Minimum Bid Price Requirement

Akari Therapeutics

05/09/2023 14:02

Akari Therapeutics PLC  AKTX.O :
    * AKARI THERAPEUTICS PLC - REGAINS COMPLIANCE WITH NASDAQ
MINIMUM
BID PRICE REQUIREMENT

Source text for Eikon:  ID:nGNXbnHJNy 
Further company coverage:  AKTX.O